Stable Isotope Labeled Compounds Market

Stable Isotope Labeled Compounds Market by Type (Carbon 13, D, Oxygen 18, N15), Application (Research, Clinical Diagnostics, Industrial), End User (Pharmaceutical & Biopharmaceutical Companies, Academic institute), Region – Global Forecast to 2024

Report Code: PH 5445 Jan, 2020, by marketsandmarkets.com

[135 Pages Report] The global stable isotope labeled compounds market size is projected to reach USD 312 million by 2024 from USD 269 million in 2019, at a CAGR of 3.0% between 2019 and 2024. The growth of this market is driven majorly by the increase in research activities in the pharmaceutical and biotechnology sector, rising proteomics research, and the rising prevalence of cancer. However, the high cost of stable isotope-labeled compounds is expected to restrain the growth of this market during the forecast period.

Stable Isotope Labelled Compounds Market-By Region

In 2018, the stable isotope labeled compounds market demand was highest from pharmaceutical & biotechnology companies

Based on end-users, the stable isotope labeled compounds market is segmented into pharmaceutical & biotechnology companies, hospitals & diagnostic centers, academic & research institutes, and other end users. The pharmaceutical and biotechnology companies segment accounted for the larger share of the market in 2018. The growth of the pharmaceutical & biotechnology segment is attributed to the increase in R&D spending, which will drive drug research activities in the industry.

Stable Isotope Labelled Compounds Market-By Region

North America market is expected to grow at the highest CAGR during the forecast period

North America is expected to dominate the stable isotope labeled compounds market. The major factors driving the growth of this market include the growth of the pharmaceutical and biopharmaceutical industry, the large nuclear industry in the US, the growth of the Canadian pharmaceutical industry, and the availability of funding in North American countries. North America is also expected to register the highest CAGR during the forecast period.

Key Market Players

The prominent players in the stable isotope labeled compounds market include PerkinElmer Inc. (US), Merck KGaA (Germany), Cambridge Isotope Laboratories, Inc. (US), URENCO Limited (UK), IsoSciences, LLC (US), Medical Isotopes, Inc. (US), Omicron Biochemicals, Inc. (US), Trace Sciences International (US), Alsachim (France), Taiyo Nippon Sanso Corporation (Japan), and Rotem Industries Israel Ltd. (Israel). Major players have focused on acquisitions, product launches, agreements, and partnerships to increase their shares in the global market.

Cambridge Isotope Laboratories (CIL) is one of the leading positions in the stable isotope-labeled compounds market. The company offers a comprehensive portfolio of stable isotope-labeled compounds for laboratories; medical, government, and academic research centers; and healthcare facilities. The company offers more than 15,000 products and has ISO 13485, ISO/IEC 17025, and ISO Guide 34 quality systems, along with cGMP production capabilities. Over the years, the company has extended its global footprint in four countries—the US, Canada, France, and Germany.

Scope of the Report:

Report Metric

Details

Market size available for years

2017–2024

Base year considered

2018

Forecast period

2019–2024

Forecast units

Value (USD)

Segments covered

Type, Application, End User, and Region

Geographies covered

North America, Europe, Asia Pacific, and Rest of the World

Companies covered

PerkinElmer Inc. (US), Merck KGaA (Germany), Cambridge Isotope Laboratories, Inc. (US), URENCO Limited (UK), IsoSciences, LLC (US), Medical Isotopes, Inc. (US), Omicron Biochemicals, Inc. (US), Trace Sciences International (US), Alsachim (France), Taiyo Nippon Sanso Corporation (Japan), PerkinElmer (US), and Rotem Industries Israel Ltd. (Israel), CortecNet (France), ISOFLEX (US), Huayi Isotopes Co (Canada), Mesbah Energy Co. (Iran),
Shanghai Research Institute Of Chemical Industry (China),  3C Molecular, Inc. (US), C/D/N/ Isotope Inc. (Canada), and Shoko Co. Ltd. (Japan)

 

 

.

The research report categorizes the stable isotope labeled compounds market into the following segments and subsegments:

By Type

  • Deuterium
  • Carbon-13
  • Oxygen-18
  • Nitrogen-15
  • Other Stable Isotopes

By Application

  • Research
  • Clinical Diagnostics
  • Industrial
  • Other Applications

By End User

  • Pharmaceutical and Biotechnology Companies
  • Academic & Research Institutes
  • Hospitals and Diagnostic Centers
  • Other End Users

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • RoE
  • Asia Pacific
  • Rest of the World

Critical questions answered in the report:

  • Which regions are likely to grow at the highest CAGR?
  • What are the recent trends affecting the stable isotope labeled compounds market?
  • Who are the key players in the market, and how intense is the competition?
  • What are the application areas of stable isotope labeled compounds?
  • What are the challenges hindering the adoption of stable isotope labeled compounds?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst



Table of Contents

1 Introduction (Page No. - 17)
    1.1 Objectives of the Study
    1.2 Market Definition
           1.2.1 Markets Scope
           1.2.2 Markets Covered
           1.2.3 Years Considered for the Study
    1.3 Currency
    1.4 Limitations
    1.5 Stakeholders

2 Research Methodology (Page No. - 20)
    2.1 Research Data
    2.2 Secondary Data
           2.2.1 Key Data From Secondary Sources
    2.3 Primary Data
           2.3.1 Key Data From Primary Sources
    2.4 Market Size Estimation
           2.4.1 Revenue Mapping-Based Market Estimation
    2.5 Data Triangulation
           2.5.1 Assumptions for the Study
           2.5.2 Limitations

3 Executive Summary (Page No. - 29)

4 Premium Insights (Page No. - 32)
    4.1 Stable Isotope-Labeled Compounds: Market Overview
    4.2 North America: Stable Isotope-Labeled Compounds, By Application (2018)
    4.3 Geographical Snapshot of the Stable Isotope-Labeled Compounds Market

5 Market Overview (Page No. - 35)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Increase in Research Activities in the Pharmaceutical and Biotechnology Sector
                    5.2.1.2 Growing Proteomics Research
                    5.2.1.3 Rising Prevalence of Cancer
           5.2.2 Restraints
                    5.2.2.1 High Cost of Stable Isotope-Labeled Compounds
           5.2.3 Opportunities
                    5.2.3.1 Rising Investments in Pharmaceutical R&D in Emerging Markets
           5.2.4 Challenges
                    5.2.4.1 Dearth of Skilled Professionals

6 Stable Isotope-Labeled Compounds Market, By Type (Page No. - 40)
    6.1 Introduction
    6.2 Hydrogen-2
           6.2.1 Growing Applications of H-2 in Pharmaceutical Research Will Drive Demand for Labeled Compounds
    6.3 Carbon-13
           6.3.1 Rising Number of Metabolomics Studies and Applications in Disease Diagnosis are Driving Market Growth
    6.4 Oxygen-18
           6.4.1 Increasing Research on Cancer is Expected to Drive Demand for O-18 Labeled Isotopes
    6.5 Nitrogen-15
           6.5.1 Expanding Applications of N-15 in Agricultural Investigation and Rising Research are Likely to Drive Market Demand
    6.6 Other Stable Isotopes

7 Stable Isotope-Labeled Compounds Market, By Application (Page No. - 50)
    7.1 Introduction
    7.2 Research
           7.2.1 Increasing Research Activities Involving Stable Isotopes to Support Market Growth
           7.2.2 Biomedical Research
           7.2.3 Pharmaceutical Research
           7.2.4 Environmental & Ecological Research
           7.2.5 Agricultural Research
    7.3 Clinical Diagnostics
           7.3.1 Increasing Adoption of Pet Scans and Gamma Imaging for Disease Staging to Support Market Growth
    7.4 Industrial Applications
           7.4.1 Rising Applications of Stable Isotopes in the Nuclear Industry and the Growing Number of Nuclear Reactors to Support Market Growth
    7.5 Other Applications

8 Stable Isotope-Labeled Compounds Market, By End User (Page No. - 60)
    8.1 Introduction
    8.2 Pharmaceutical & Biotechnology Companies
           8.2.1 Increase in R&D Activities is Expected to Drive Demand for Stable Isotope-Labeled Compounds
    8.3 Academic & Research Institutes
           8.3.1 Rising Prevalence of Diseases and Growing Research Into Therapies have Driven the Growth of This End-User Segment
    8.4 Hospitals & Diagnostic Centers
           8.4.1 Adoption of Stable Isotopes has Increased Owing to the Rising Prevalence of Target Diseases
    8.5 Other End Users

9 Stable Isotope-Labeled Compounds Market, By Region (Page No. - 69)
    9.1 Introduction
    9.2 North America
           9.2.1 US
                    9.2.1.1 The US Dominates the North American Market
           9.2.2 Canada
                    9.2.2.1 Availability of Funding Will Drive the Market in Canada
    9.3 Europe
           9.3.1 Germany
                    9.3.1.1 Germany is the Fastest-Growing Market in Europe
           9.3.2 UK
                    9.3.2.1 Favorable Scenario for Environmental Research and Increasing Prevalence of Cancer are Key Growth Drivers in the UK
           9.3.3 France
                    9.3.3.1 France has A Large and Well-Developed Biotech Industry
           9.3.4 Italy
                    9.3.4.1 Strong Government Support for Research has Stimulated Market Growth in Italy
           9.3.5 Spain
                    9.3.5.1 Rising Research Activity and Expenditure Shows Significant Market Growth Potential in Spain
           9.3.6 Rest of Europe
    9.4 Asia Pacific
           9.4.1 China
                    9.4.1.1 China Dominates the Market in the APAC
           9.4.2 Japan
                    9.4.2.1 Growing Support and Funding have Raised Research Intensity in Japan
           9.4.3 India
                    9.4.3.1 Government Initiatives have Strengthened the Life Science Industry in India
           9.4.4 Australia
                    9.4.4.1 Growing Funding for Research and Collaborations have Supported Market Growth in Australia
           9.4.5 Rest of Asia Pacific
    9.5 Rest of the World

10 Competitive Landscape (Page No. - 99)
     10.1 Overview
     10.2 Market Share Analysis, 2018
     10.3 Competitive Scenario
     10.4 Competitive Leadership Mapping (Overall Market) (2018)
             10.4.1 Visionary Leaders
             10.4.2 Innovators
             10.4.3 Dynamic Differentiators
             10.4.4 Emerging Companies

11 Company Profiles (Page No. - 103)
(Business Overview, Products Offered, Recent Developments, MnM View)*
     11.1 Cambridge Isotope Laboratories
     11.2 Merck KGaA
     11.3 URENCO Limited
     11.4 IsoSciences
     11.5 Medical Isotopes
     11.6 Omicron Biochemicals
     11.7 Trace Sciences International
     11.8 Alsachim
     11.9 Taiyo Nippon Sanso Corporation
     11.10 Perkinelmer
     11.11 Rotem Industries Israel
     11.12 Boc Sciences
     11.13 Cortecnet
     11.14 Isoflex
     11.15 Huayi Isotopes Co.
     11.16 Mesbah Energy Co.
     11.17 Shanghai Research Institute of Chemical Industry
     11.18 13c Molecular
     11.19 C/D/N Isotope
     11.20 Shoko Co.

*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 128)
     12.1 Discussion Guide
     12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.3 Available Customizations
     12.4 Related Reports
     12.5 Author Details


List of Tables (118 Tables)

Table 1 Company Drug Pipelines, 2019
Table 2 Top Investors in R&D, 2016 vs 2017
Table 3 Global Cancer Incidence, 2018 vs 2025
Table 4 Government Funding Programs for Pharmaceutical R&D in Emerging Nations
Table 5 Stable Isotope-Labeled Compounds Market, By Type, 2017–2024 (USD Million)
Table 6 H-2 Labeled Compounds Market, By Region, 2017–2022 (USD Million)
Table 7 North America: H-2 Labeled Compounds Market, By Country, 2017–2024 (USD Million)
Table 8 Europe: H-2 Labeled Compounds Market, By Country, 2017–2024 (USD Million)
Table 9 APAC: H-2 Labeled Compounds Market, By Country, 2017–2024 (USD Thousand)
Table 10 C-13 Labeled Compounds Market, By Region, 2017–2024 (USD Million)
Table 11 North America: C-13 Labeled Compounds Market, By Country, 2017–2024 (USD Million)
Table 12 Europe: C-13 Labeled Compounds Market, By Country, 2017–2024 (USD Million)
Table 13 APAC: C-13 Labeled Compounds Market, By Country, 2017–2024 (USD Thousand)
Table 14 O-18 Labeled Compounds Market, By Region, 2017–2024 (USD Million)
Table 15 North America: O-18 Labeled Compounds Market, By Country, 2017–2024 (USD Million)
Table 16 Europe: O-18 Labeled Compounds Market, By Country, 2017–2024 (USD Million)
Table 17 APAC: O-18 Labeled Compounds Market, By Country, 2017–2024 (USD Thousand)
Table 18 N-15 Labeled Compounds Market, By Region, 2017–2022 (USD Million)
Table 19 North America: N-15 Labeled Compounds Market, By Country, 2017–2024 (USD Million)
Table 20 Europe: N-15 Labeled Compounds Market, By Country, 2017–2024 (USD Million)
Table 21 APAC: O-18 Labeled Compounds Market, By Country, 2017–2024 (USD Thousand)
Table 22 Other Market, By Region, 2017–2022 (USD Thousand)
Table 23 North America: Other Market, By Country, 2017–2024 (USD Thousand)
Table 24 Europe: Other Stable Isotope-Labeled Compounds Market, By Country, 2017–2024 (USD Thousand)
Table 25 APAC: Other Market, By Country, 2017–2024 (USD Thousand)
Table 26 Market, By Application, 2017–2024 (USD Million)
Table 27 Market for Research Applications, By Region, 2017–2024 (USD Million)
Table 28 North America: Market for Research Applications, By Country, 2017–2024 (USD Million)
Table 29 Europe: Market for Research Applications, By Country, 2017–2024 (USD Million)
Table 30 APAC: Stable Isotope-Labeled Compounds Market for Research Applications, By Country, 2017–2024 (USD Million)
Table 31 Market for Clinical Diagnostic Applications, By Region, 2017–2024 (USD Million)
Table 32 North America: Market for Clinical Diagnostic Applications, By Country, 2017–2024 (USD Million)
Table 33 Europe: Market for Clinical Diagnostic Applications, By Country, 2017–2024 (USD Million)
Table 34 APAC: Market for Clinical Diagnostic Applications, By Country, 2017–2024 (USD Thousand)
Table 35 Stable Isotope-Labeled Compounds Market for Industrial Applications, By Region, 2017–2024 (USD Million)
Table 36 North America: Market for Industrial Applications, By Country, 2017–2024 (USD Million)
Table 37 Europe: Market for Industrial Applications, By Country, 2017–2024 (USD Thousand)
Table 38 APAC: Market for Industrial Applications, By Country, 2017–2024 (USD Thousand)
Table 39 Market for Other Applications, By Region, 2017–2024 (USD Million)
Table 40 North America: Market for Other Applications, By Country, 2017–2024 (USD Thousand)
Table 41 Europe: Market for Other Applications, By Country, 2017–2024 (USD Thousand)
Table 42 APAC: Stable Isotope-Labeled Compounds Market for Other Applications, By Country, 2017–2024 (USD Thousand)
Table 43 Market, By End User, 2017–2024 (USD Million)
Table 44 Market for Pharmaceutical & Biotechnology Companies, By Region, 2017–2024 (USD Million)
Table 45 North America: Market for Pharmaceutical & Biotechnology Companies, By Country, 2017–2024 (USD Million)
Table 46 Europe: Market for Pharmaceutical & Biotechnology Companies, By Country, 2017–2024 (USD Million)
Table 47 APAC: Market for Pharmaceutical & Biotechnology Companies, By Country, 2017–2024 (USD Thousand)
Table 48 Market for Academic & Research Institutes, By Region, 2017–2024 (USD Million)
Table 49 North America: Stable Isotope-Labeled Compounds Market for Academic & Research Institutes, By Country, 2017–2024 (USD Million)
Table 50 Europe: Market for Academic & Research Institutes, By Country, 2017–2024 (USD Million)
Table 51 APAC: Market for Academic & Research Institutes, By Country, 2017–2024 (USD Thousand)
Table 52 Market for Hospitals & Diagnostic Centers, By Region, 2015–2022 (USD Million)
Table 53 North America: Stable Isotope-Labeled Compounds Market for Hospitals & Diagnostic Centers, By Country, 2017–2024 (USD Thousand)
Table 54 Europe: Market for Hospitals & Diagnostic Centers, By Country, 2017–2024 (USD Thousand)
Table 55 APAC: Market for Hospitals & Diagnostic Centers, By Country, 2017–2024 (USD Thousand)
Table 56 Market for Other End Users, By Region, 2015–2022 (USD Million)
Table 57 North America: Market for Other End Users, By Country, 2017–2024 (USD Thousand)
Table 58 Europe: Market for Other End Users, By Country, 2017–2024 (USD Thousand)
Table 59 APAC: Market for Other End Users, By Country, 2017–2024 (USD Thousand)
Table 60 Market, By Region, 2017–2024 (USD Million)
Table 61 North America: Market, By Country, 2017–2024 (USD Million)
Table 62 North America: Market, By Type, 2017–2024 (USD Million)
Table 63 North America: Market, By Application, 2017–2024 (USD Million)
Table 64 North America: Market, By End User, 2017–2024 (USD Million)
Table 65 US: Market, By Type, 2017–2024 (USD Million)
Table 66 US: Market, By Application, 2017–2024 (USD Million)
Table 67 US: Market, By End User, 2017–2024 (USD Million)
Table 68 Canada: Stable Isotope-Labeled Compounds Market, By Type, 2017–2024 (USD Thousand)
Table 69 Canada: Market, By Application, 2017–2024 (USD Thousand)
Table 70 Canada: Market, By End User, 2017–2024 (USD Thousand)
Table 71 Europe: Market, By Country, 2017–2024 (USD Million)
Table 72 Europe: Market, By Type, 2017–2024 (USD Million)
Table 73 Europe: Market, By Application, 2017–2024 (USD Million)
Table 74 Europe: Market, By End User, 2017–2024 (USD Million)
Table 75 Germany: Market, By Type, 2017–2024 (USD Million)
Table 76 Germany: Stable Isotope-Labeled Compounds Market, By Application, 2017–2024 (USD Million)
Table 77 Germany: Market, By End User, 2017–2024 (USD Million)
Table 78 UK: Market, By Type, 2017–2024 (USD Million)
Table 79 UK: Market, By Application, 2017–2024 (USD Million)
Table 80 UK: Market, By End User, 2017–2024 (USD Million)
Table 81 France: Market, By Type, 2017–2024 (USD Thousand)
Table 82 France: Stable Isotope-Labeled Compounds Market, By Application, 2017–2024 (USD Thousand)
Table 83 France: Market, By End User, 2015–2022 (USD Thousand)
Table 84 Italy: Market, By Type, 2017–2024 (USD Thousand)
Table 85 Italy: Market, By Application, 2017–2024 (USD Thousand)
Table 86 Italy: Market, By End User, 2017–2024 (USD Thousand)
Table 87 Spain: Market, By Type, 2017–2024 (USD Thousand)
Table 88 Spain: Market, By Application, 2017–2024 (USD Thousand)
Table 89 Spain: Stable Isotope-Labeled Compounds Market, By End User, 2017–2024 (USD Thousand)
Table 90 Pharmaceutical R&D Expenditure in RoE Countries (2016)
Table 91 RoE: Market, By Type, 2017–2024 (USD Thousand)
Table 92 RoE: Market, By Application, 2017–2024 (USD Thousand)
Table 93 RoE: Market, By End User, 2017–2024 (USD Thousand)
Table 94 Number of Nuclear Reactors in the Asia Pacific (August 2019)
Table 95 Asia Pacific: Market, By Country, 2017–2024 (USD Million)
Table 96 Asia Pacific: Market, By Type, 2017–2024 (USD Million)
Table 97 Asia Pacific: Market, By Application, 2017–2024 (USD Million)
Table 98 Asia Pacific: Stable Isotope-Labeled Compounds Market, By End User, 2015–2022 (USD Million)
Table 99 China: Market, By Type, 2017–2024 (USD Million)
Table 100 China: Market, By Application, 2017–2024 (USD Million)
Table 101 China: Market, By End User, 2017–2024 (USD Million)
Table 102 Japan: Market, By Type, 2017–2024 (USD Thousand)
Table 103 Japan: Market, By Application, 2015–2022 (USD Thousand)
Table 104 Japan: Market, By End User, 2017–2024 (USD Thousand)
Table 105 India: Market, By Type, 2017–2024 (USD Thousand)
Table 106 India: Market, By Application, 2017–2024 (USD Thousand)
Table 107 India: Stable Isotope-Labeled Compounds Market, By End User, 2017–2024 (USD Thousand)
Table 108 Australia: Market, By Type, 2017–2024 (USD Thousand)
Table 109 Australia: Market, By Application, 2017–2024 (USD Thousand)
Table 110 Australia: Market, By End User, 2017–2024 (USD Thousand)
Table 111 RoAPAC: Market, By Type, 2017–2024 (USD Thousand)
Table 112 RoAPAC: Market, By Application, 2017–2024 (USD Thousand)
Table 113 RoAPAC: Stable Isotope-Labeled Compounds Market, By End User, 2017–2024 (USD Thousand)
Table 114 RoW: Market, By Type, 2017–2024 (USD Thousand)
Table 115 RoW: Market, By Application, 2017–2024 (USD Thousand)
Table 116 RoW: Market, By End User, 2017–2024 (USD Thousand)
Table 117 Agreements (2016–2019)
Table 118 Product Launches (2016-2019)


List of Figures (21 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Research Methodology: Hypothesis Building
Figure 4 Market Size Estimation: Stable Isotope-Labeled Compounds Market
Figure 5 Market Data Triangulation Methodology
Figure 6 Market, By Type, 2019 vs 2024
Figure 7 Market, By Application, 2019 vs 2024
Figure 8 Market, By End User, 2019 vs 2024
Figure 9 Geographic Snapshot of the Stable Isotope-Labeled Compounds Market
Figure 10 Increase in Research in the Pharmaceutical and Biotechnology Sectors Will Drive the Growth of the Market
Figure 11 Research Segment Accounted for the Largest Share of the North American Market in 2018
Figure 12 North America to Register the Highest Growth During the Forecast Period
Figure 13 Market: Drivers, Restraints, Opportunities, and Challenges
Figure 14 North America Dominates the Market in 2019
Figure 15 Asia Pacific: Market Snapshot
Figure 16 Market Ranking of Key Players, 2018
Figure 17 Competitive Leadership Mapping: Stable Isotope-Labeled Compounds Market
Figure 18 Merck KGaA: Company Snapshot
Figure 19 URENCO Limited: Company Snapshot (2018)
Figure 20 Taiyo Nippon Sanso Corporation: Company Snapshot (2018)
Figure 21 Perkinelmer: Company Snapshot (2018)

The stable isotope labeled compounds market study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the stable isotope labeled compounds market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the stable isotope labeled compounds market. The primary sources from the demand side included industry experts, such as researchers & scientists and industry experts from medical device companies. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

A breakdown of the primary respondents is provided below:

Stable Isotope Labelled Compounds Market-By Region

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The stable isotope labeled compounds market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (segmental analysis of major segments) and top-down approach (assessment of utilization/adoption/penetration trends, by technology, component, end user, and region).

Data Triangulation

After arriving at the market size, the stable isotope labeled compounds market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments.

Objectives of the Study

  • To define, describe, segment, and forecast the global stable isotope labeled compounds market by type, application, end user, and region
  • To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the stable isotopes labeled compounds market in five main regions, namely, North America, Europe, the Asia Pacific, and Rest of the World
  • To profile key players in the global stable isotope labeled compounds market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments such as product/service launches, partnerships, and collaborations in the stable isotope labeled compounds market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (Up to 3)
Report Code
PH 5445
Published ON
Jan, 2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Stable Isotope Labeled Compounds Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

...

Digital Virtual Assistant - MarketsandMarkets

Home